SLC5A2 and diabetes mellitus: It was also supposed that the decrease in UGE followed the same pattern as the glucose-lowering effect progressively attenuated with impaired renal function (measured by HbA1c) (17), although in rodent models of diabetes, it was suggested that glycosuria may not be the only mechanism for the glucose-lowering effect of SGLT2 inhibitors.